TrialDrug design, development and therapy2017

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.

Krzysztof Nosek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.